Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22984449 | 0.77 | — | — | |
| SCHEMBL21149813 | 0.72 | — | — | |
| SCHEMBL23966215 | 0.69 | RGS4 (0.30) | — | |
| SCHEMBL18854237 | 0.67 | — | — | |
| SCHEMBL172560 | 0.66 | CARM1 (0.44) | L3MBTL1 | |
| SCHEMBL24724037 | 0.64 | HRH3 (0.48) | — | |
| SCHEMBL28107773 | 0.64 | HRH3 (0.48) | — | |
| SCHEMBL12716 | 0.64 | HRH3 (0.48) | — | |
| SCHEMBL8074673 | 0.64 | HRH3 (0.48) | — | |
| SCHEMBL16270534 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210129125-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210129125-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | L3MBTL1 3427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.